Shareholder Alert: Ademi LLP Investigates Whether Alimera Sciences, Inc. Has Obtained a Fair Price for Its Public Shareholders
Shareholder Alert: Ademi LLP Investigates Whether Alimera Sciences, Inc. Has Obtained a Fair Price for Its Public Shareholders
MILWAUKEE, June 24, 2024 /PRNewswire/ -- Ademi LLP is investigating Alimera (Nasdaq: ALIM) for possible breaches of fiduciary duty and other violations of law in its transaction with ANI Pharmaceuticals.
Ademi LLP正在調查Alimera（Nasdaq: ALIM）與ANI Pharmaceuticals交易可能存在的違反信託職責和其他法律的行爲。.
Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
點擊此處了解如何加入或致電Guri Ademi，免費電話：866-264-3995。您不需要付出任何費用或承擔任何責任。
In the transaction, Alimera public shareholders will receive only $5.50 per share in cash at closing and one non-tradable contingent value right (CVR) representing the right to receive up to $0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027. The transaction agreement unreasonably limits competing transactions for Alimera by imposing a significant penalty if Alimera accepts a competing bid. Alimera insiders will receive substantial benefits as part of change of control arrangements.
在該交易中，Alimera的公共股東將在收盤時僅獲得每股5.50美元的現金以及一個不可交易的附帶價值權（CVR），該權利代表在2026年和2027年達到特定淨收入目標時獲得每股高達0.50美元的權利。該交易協議通過對Alimera提出競購而不合理地限制了競爭交易，如果Alimera接受競爭性報價，則會面臨重大處罰。作爲變更控制安排的一部分，Alimera內部人員將獲得大量利益。
We are investigating the conduct of Alimera's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.
我們正在調查Alimera的董事會的行爲，以及他們是否履行了對所有股東的信託職責。
If you own Alimera common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or
如果您擁有Alimera普通股並希望獲得更多信息，請通過[email protected]或免費電話聯繫Guri Ademi：866-264-3995或
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
我們專門從事全國範圍內有關收購、合併和個人股東權利的股東訴訟。欲了解更多信息，請隨時與我們聯繫。律師廣告。之前的業績不保證類似的結果。
Contacts
聯繫方式
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
Ademi LLP
Guri Ademi
免費電話：(866) 264-3995
傳真：(414) 482-8001
SOURCE Ademi LLP
信息來源：Ademi LLP
譯文內容由第三人軟體翻譯。